Tiotropium (Spiriva): the LAMA maintenance therapy with COPD and the Respimat technique

Tiotropium (Spiriva) explained clearly: the LAMA maintenance therapy with COPD, why it is no emergency spray and how the Respimat inhalation works step by…

See more detail

Tiotropium (Spiriva): the LAMA maintenance therapy with COPD and the Respimat technique

Tiotropium, better known to many under the brand name Spiriva, is one of the most important medicines in the long-term therapy of COPD. But with an agent that one inhales every day, two things matter that specialist pages often treat only briefly: understanding which role it plays in the treatment and inhaling it correctly. This guide explains understandably why tiotropium is a maintenance agent and no emergency spray, and leads you step by step through the Respimat inhalation technique, supplemented by the note on official instruction videos. It does not replace medical advice but helps you use the agent safely and effectively. Because precisely with inhaled medicines it applies: the best medicine is of little use if it does not reach the lung correctly.

At a glance

  • Tiotropium (Spiriva) is a long-acting muscarinic antagonist (LAMA) that widens the airways.
  • It is a cornerstone of the maintenance therapy with COPD and is inhaled once a day.
  • The effect lasts over 24 hours but sets in slowly: it is no emergency spray.
  • With the Respimat, two spray puffs together form the full daily dose.
  • The most common side effect is dry mouth; the spray mist should not get into the eyes.

What is tiotropium (Spiriva) and how does it work?

Tiotropium belongs to the group of long-acting muscarinic antagonists, in technical jargon LAMA. To understand its effect, a look at the control of the airways helps. The muscle around the bronchi is influenced among other things by the body's own messenger acetylcholine. If acetylcholine binds to its docking points, the muscarinic receptors, the muscle contracts and the airways narrow. With diseases such as COPD this narrowing is a central problem that intensifies the breathlessness. The airways are then already permanently narrowed anyway, and every additional narrowing through acetylcholine makes breathing even harder.

Exactly here is where tiotropium intervenes. It blocks the muscarinic receptors, especially the M3 receptor important for the bronchi, so that acetylcholine can no longer work there. As a result the muscle stays relaxed, the airways widen, and breathing becomes easier. This widening of the bronchi is called bronchodilation. An additional effect is that less viscous mucus is formed. The special thing about tiotropium is that it detaches only very slowly from the M3 receptor again. As a result the effect lasts over 24 hours, which is why inhaling once a day is enough. This is a practical advantage over older, shorter-acting agents and makes it easier to keep up the treatment in everyday life. Tiotropium is prescription only. Because only one application a day is necessary, it can be built well into fixed daily routines, for example in the morning after getting up, which supports the therapy adherence.

Maintenance therapy, not emergency help

Tiotropium keeps the airways open long-term by being inhaled regularly once a day. The effect sets in slowly, only after about half an hour, and then lasts a long time. Therefore it is no emergency spray: with sudden shortness of breath it does not work fast enough. For the acute moment you need your fast-acting emergency spray that widens the bronchi within minutes. These two roles, lasting protection and acute help, must not be confused, and the emergency spray never replaced by tiotropium. Anyone who knows both agents and knows when which is needed is on the safe side in everyday life and in the emergency.

The LAMA maintenance therapy with COPD

Tiotropium is meant above all for COPD, the chronic obstructive pulmonary disease. In it the airways are permanently narrowed and inflamed, frequently as a consequence of long-term smoking, which leads to cough, expectoration and above all increasing shortness of breath. The treatment of COPD rests on a regular maintenance therapy that keeps the airways open as lastingly as possible. Unlike a cold, which passes again, COPD is a chronic disease that needs a lasting treatment. Here long-acting bronchodilators such as the LAMA are the cornerstone. They intervene exactly at the permanent narrowing that makes breathing with COPD so strenuous, and create a bit more air day and night.

As a LAMA, tiotropium belongs in the treatment guidelines in all phases of COPD to the basic therapy. Its goal is not only to widen the airways and ease the breathlessness but also to reduce acute worsenings, so-called exacerbations, and the associated hospital stays. Scientific assessments, for example by the German Institute for Quality and Efficiency in Health Care, have confirmed for tiotropium advantages in quality of life and in rarer exacerbations. Precisely fewer acute flare-ups often also mean for those affected fewer hospital stays and more security in everyday life. Besides COPD, tiotropium in the Respimat form has also found a place with severe asthma, but there in a different, subordinate role: as an add-on therapy when the combination of inhaled cortisone and a long-acting beta-2 agonist is not enough. With COPD, on the other hand, tiotropium stands at the centre of the long-term treatment. Important is to understand the therapy not as a short-term cure but as a lasting accompaniment: tiotropium does not heal COPD, but it can keep the airways open, ease the breathlessness and noticeably improve the quality of life, as long as it is applied regularly.

Do not forget the daily inhalation

A maintenance therapy only works if it is consistently kept up. brite helps you be reminded of the daily inhalation and keep your airway medicines in view.

Try brite for free

Free · ad-free · GDPR-compliant

The Respimat inhalation technique step by step

With an inhaled medicine, the correct technique co-decides how much active ingredient actually reaches the lung. Exactly here many specialist pages stay too theoretical and describe the technique in a few, brief keywords without really making it comprehensible. Tiotropium exists in different inhalers, among them powder inhalers with capsules and the Respimat, which releases the solution as a fine, slowly emerging mist. This gentle mist makes the Respimat pleasant for many people but demands a calm, coordinated technique. Unlike with a powder inhaler, with which one has to breathe in forcefully and fast, with the Respimat it matters precisely to breathe in slowly and evenly, which fits the slowly emerging mist. The following steps are a simplified orientation and do not replace the instruction in the practice or pharmacy.

First breathe out calmly and completely, but never into the device. Take a moment for it and sit upright best, so that the lung can unfold well. Then enclose the mouthpiece firmly with the lips, without covering the side air vents. Now release the spray puff and breathe in at the same moment slowly and deeply through the mouth, so that the fine mist reaches deep into the lung with the breath. Afterwards hold your breath for a few seconds, so that the active ingredient can spread in the airways, and then breathe out calmly. Do not breathe back into the device but to the side or through the nose, so that no moisture builds up. For the full daily dose you repeat this process, because with the Respimat as a rule two spray puffs in a row are necessary. Take a brief moment between the two spray puffs, keep breathing normally and then carry out the second spray puff just as carefully as the first. Because a correct technique is so important, it is worth having it shown to you in person once and additionally watching the official instruction videos of the manufacturers or of lung specialist societies, which show every step in the picture. A common mistake is to breathe in too hastily and too briefly or not to start the spray puff and the breath at the same time, so that a part of the mist gets stuck in the mouth instead of reaching the lung. Anyone who takes a calm moment for the application gets clearly more out of every spray puff.

Watch out for clean technique and the eyes

Breathe out before the spray puff, enclose the mouthpiece tightly and breathe in slowly and deeply when releasing, then briefly hold your breath. With the Respimat take both spray puffs, since together they form the daily dose. Watch out that the spray mist does not get into the eyes, because that can with predisposed people increase the eye pressure or trigger a glaucoma attack. With eye pain, visual disturbances, a red eye or suddenly blurred vision after the application, seek medical advice. Wash your hands best after inhaling in case some spray mist got onto them. Have the technique shown to you professionally.

Side effects, care and what you should observe

Tiotropium is as a rule well tolerated. The by far most common side effect is dry mouth, which is mostly mild and often improves with time; regular drinking and rinsing the mouth can ease it. Less often constipation, cough or hoarseness occur. Because tiotropium belongs to the anticholinergics, caution is required if a narrow-angle glaucoma, problems with urinating or an enlarged prostate are known; in these cases the use should be weighed up medically. With certain heart diseases too a careful weighing-up is sensible. Important is moreover that tiotropium is not applied at the same time as other inhaled anticholinergics. Otherwise clinically significant interactions are rare, which simplifies the application in everyday life.

Besides the correct application, a simple care of the inhaler also belongs to it. Wipe the mouthpiece of the Respimat regularly, for example once a week, with a damp cloth, but never immerse the device in water. Store it protected from moisture and think in good time of a follow-up prescription, since each inhaler delivers only a certain number of applications. Some Respimat models show via a display how many applications are still left, which makes the planning easier. Tiotropium unfolds its benefit only with regular, once-daily application, best always at the same time of day. A stopping on your own can lead to the airways narrowing again and the complaints returning. If you want to change something about the treatment, discuss this with your medical practice. This way it can be avoided that through an uncontrolled stop the painstakingly reached breathing stability is lost again, and a fitting solution can be found together.

Aspect What you should know about tiotropium (Spiriva)
Active ingredient class long-acting muscarinic antagonist (LAMA)
Main use maintenance therapy with COPD, add-on with severe asthma
Application once a day, with the Respimat two spray puffs
In the acute attack not suitable, no emergency spray
Most common side effect dry mouth, spray mist not into the eyes
brite App

Airway therapy reliably in everyday life

Precisely with a long-term therapy like with tiotropium, which should take place every day and with correct technique, a clear overview helps. Anyone who uses several inhalers and medicines side by side otherwise easily loses track of which agent is meant when and for what. brite helps you manage your inhalers and medicines, be reminded of the daily application and think in good time of a follow-up prescription.

  • Clear, digital medication plan
  • Reminders for the daily inhalation
  • Think of supply and follow-up prescription in good time
Start for free now
brite App, medication plan and interaction check

In sum, tiotropium (Spiriva) is a central agent of the COPD long-term therapy that keeps the airways open over 24 hours and can prevent exacerbations. For it to work, two things matter: the regular, once-daily application and the correct inhalation technique, precisely with the Respimat with its two spray puffs. With COPD, tiotropium is a cornerstone of the treatment. With severe asthma it can serve as an add-on therapy. And when shortness of breath occurs suddenly and acutely, it is not tiotropium but the fast-acting emergency spray that is needed. With this knowledge, the right technique and a regular application, you can get the best out of your maintenance therapy and breathe more freely in everyday life.

Well prepared for the doctor's appointment

Add your inhalers and medicines to brite for free and record questions about the technique. This way you can have the application specifically shown to you and not forget anything important.

Try for free

Free · ad-free · GDPR-compliant

Frequently asked questions about tiotropium (Spiriva)

Tiotropium, brand name Spiriva, is a bronchodilating active ingredient from the group of long-acting muscarinic antagonists (LAMA). It blocks the muscarinic receptors, above all the M3 receptor, so that the airway muscle stays relaxed and the bronchi widen. Because it detaches only slowly from the receptor, the effect lasts over 24 hours, so that inhaling once a day is enough.
Tiotropium is used above all for the lasting maintenance therapy of COPD and belongs there to the basic therapy, to keep the airways open and reduce exacerbations. In the Respimat form it is additionally approved with severe asthma, then as an add-on to inhaled cortisone and long-acting beta-2 agonists. It is an agent for the long-term treatment, not for acute situations.
No. The effect only sets in after about half an hour and lasts a long time, which is why tiotropium is not suitable for the emergency. With acute shortness of breath you need your fast-acting emergency spray that widens the bronchi in minutes. Never stop the emergency spray and do not replace it with tiotropium. Both have different tasks.
First breathe out calmly and completely, but not into the device. Enclose the mouthpiece firmly without covering the air vents. Release the spray puff while you breathe in slowly and deeply, and afterwards hold your breath briefly. For the full daily dose, mostly two spray puffs are necessary. Have the technique shown to you professionally and use official instruction videos.
With the Spiriva Respimat, a single spray puff delivers only half the daily dose. Only two consecutive spray puffs give the effective daily dose. Two puffs once a day therefore belong together and are the normal, intended application, no double dose. Important is to inhale both correctly and not to leave one out.
Most common is dry mouth, mostly mild; drinking and rinsing the mouth help. Less often constipation, cough or hoarseness occur. The spray mist should not get into the eyes, since this can with predisposed people increase the eye pressure. With narrow-angle glaucoma, problems with urinating or certain heart diseases, the application should be weighed up medically.
Tiotropium only works with regular, once-daily application at the same time. A forgotten dose you catch up as soon as you think of it, but not the double amount at once. A stopping on your own can lead to the airways narrowing again and the complaints returning. Please discuss changes medically.
Wipe the mouthpiece about once a week with a damp cloth, but never immerse the inhaler in water and let no moisture into the inside. Store the device at room temperature and protected from moisture and observe the package leaflet on durability. Think in good time of a follow-up prescription so that the long-term therapy is not interrupted.
No. With asthma the anti-inflammatory treatment with inhaled cortisone is in the foreground. Tiotropium in the Respimat form comes into question there only as an add-on therapy when the combination of inhaled corticosteroid and a long-acting beta-2 agonist is not enough. Unlike with COPD, it is therefore with asthma no sole treatment. The decision is made by the medical practice.

Sources

  • Gelbe Liste: tiotropium, use, dosage forms, Respimat dosing
  • PharmaWiki: tiotropium bromide, LAMA, mechanism, dry mouth
  • Pharmazeutische Zeitung: profile tiotropium, LAMA basic therapy with COPD
  • DocCheck Flexikon: tiotropium bromide, M3 antagonism, 24-hour effect
  • IQWiG: benefit assessment tiotropium with COPD, exacerbations and quality of life
  • Prescribing information Spiriva Respimat (Boehringer Ingelheim): use and dosing

This guide serves general information and does not replace medical advice, diagnosis or treatment. It contains no binding dosage recommendation and no complete inhalation instruction. Tiotropium is prescription only and no emergency agent. Have the correct inhalation technique shown to you medically or in the pharmacy and observe the package leaflet. With acute shortness of breath use your emergency spray and seek medical help with persistent or severe complaints.